Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies
Musalula Sinkala et al. report that collectively, specific mutations of genes in 5 MAPK pathways are associated with worse patient survival. They identify gene components that are pharmacologically vulnerable to pathway inhibitors in cancer cell models, suggesting potential clinical applications of...
Main Authors: | Musalula Sinkala, Panji Nkhoma, Nicola Mulder, Darren Patrick Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-020-01552-6 |
Similar Items
-
Proteogenomic analysis of pancreatic cancer subtypes.
by: Doris Kafita, et al.
Published: (2021-01-01) -
Mutational landscape of cancer-driver genes across human cancers
by: Musalula Sinkala
Published: (2023-08-01) -
Kidney injury molecule-1 and microalbuminuria levels in Zambian population: biomarkers of kidney injury
by: Mildred Zulu, et al.
Published: (2016-05-01) -
A genome-wide association study identifies distinct variants associated with pulmonary function among European and African ancestries from the UK Biobank
by: Musalula Sinkala, et al.
Published: (2023-01-01) -
High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs.
by: Doris Kafita, et al.
Published: (2021-01-01)